Mylan Agrees to $465M EpiPen Settlement with U.S.

Mylan NV will pay the U.S. government $465 million in a settlement over how it charged Medicaid for its EpiPen allergy shot.

The agreement with the Department of Justice and other agencies resolves “all potential rebate liability claims by federal and state governments” Mylan said in a statement Oct. 7. The shares rose 8.5 percent to $39 in trading after the markets closed in New York. As part of settlement, there was no admission of wrongdoing by Mylan or its employees.

The U.S. Centers for Medicare & Medicaid Services, or CMS, said in a letter earlier this week that Mylan ...